Showing results (391-400 of 421) with videos related to
Sort By:
Pageof 43
IJTLD Open|March 18, 2026
Linkage to TB and HIV care for persons who smoke illicit drugs: a prospective cohort studyS Thomson, V Overbeck, D Theron, et al.Bioorganic & Medicinal Chemistry|September 1, 1996
Discovery and optimization of nonpeptide HIV-1 protease inhibitorsP J Tummino, J V Prasad, D Ferguson, et al.The Journal of Experimental Medicine|July 1, 2004
Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasionDanielle Zernich, Anthony W Purcell, Whitney A Macdonald, et al.Cancer|April 7, 2021
Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: A retrospective review of 90,000 womenSarah D Tait, Yi Ren, Cushanta C Horton, et al.Tissue Antigens|November 1, 2007
SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in TasmaniansR K Burfoot, C J Jensen, J Field, et al.Journal of Medicinal Chemistry|December 13, 2007
Substituted pyrazoles as hepatoselective HMG-CoA reductase inhibitors: discovery of (3R,5R)-7-[2-(4-fluoro-phenyl)-4-isopropyl-5-(4-methyl-benzylcarbamoyl)-2H-pyrazol-3-yl]-3,5-dihydroxyheptanoic acid (PF-3052334) as a candidate for the treatment of hypercholesterolemiaJeffrey A Pfefferkorn, Chulho Choi, Scott D Larsen, et al.Immunity|December 17, 2013
Thymic stromal lymphopoietin-mediated extramedullary hematopoiesis promotes allergic inflammationMark C Siracusa, Steven A Saenz, Elia D Tait Wojno, et al.Nature Immunology|April 5, 2016
Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammationLaurel A Monticelli, Michael D Buck, Anne-Laure Flamar, et al.Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Nonpeptidic HIV protease inhibitors: 6-alkyl-5,6-dihydropyran-2-ones possessing a novel and achiral 3-(2-t-butyl-5-methyl-4-sulfamate)phenylthio moietyJ V Vara Prasad, L J Markoski, F E Boyer, et al.Bioorganic & Medicinal Chemistry Letters|December 25, 2007
Hepatoselectivity of statins: design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitorsWilliam K C Park, Robert M Kennedy, Scott D Larsen, et al.Pageof 43